natgillin/translations-raw huggingface dataset:
Keep your tablets in a safe place where children cannot see or reach them.
Tablete shranjujte na varnem mestu, kjer jih otroci ne morejo videti ali doseči.
51689 Reims Cedex France
51689 Reims Cedex Francija
Food slightly decreases the rate but not the extent of absorption.
Hrana nekoliko zmanjša hitrost absorpcije, ne pa njenega obsega.
After the Commission Decision the Member State Competent Authorities, in liaison with the Reference Member State, will update the product information as required.
Po odločbi Komisije bodo pristojni organi držav članic, v povezavi z referenčno državo članico posodobili podatke o zdravilu, kot je potrebno.
This would be seen in a blood test.
To se pokaže s preiskavo krvi.
Long-term safety data in children and adolescents are not available.
Dolgoročnih podatkov o varnosti pri otrocih in mladostnikih ni.
Final height data were not available.
Podatki o končni telesni višini niso bili na voljo.
If you forget to take a dose, just take your next dose as normal.
Če ste pozabili vzeti odmerek, zgolj vzemite naslednji odmerek kot po navadi.
Detailed information on this medicine is available on the web site of {MA/Agency}
Podrobne informacije o zdravilu so objavljene na spletni strani {DČ/agencija}
Corticoid supplements are therefore not needed.
Dodajanje kortikoidov zato ni potrebno.
- if you have problems with your liver or kidneys.
- če imate težave z jetri ali ledvicami.
Keep your tablets in the container they came in.
Tablete shranjujte v vsebniku, v katerem ste jih dobili.
All patients received treatment with vitamin D and calcium.
Vse bolnice so prejemale zdravljenje z vitaminom D in kalcijem.
If bleeding persists, further evaluation should be considered.
Če krvavitev traja, je potrebno dodatno ovrednotenje.
Do not take a double dose (two doses at the same time) to make up for a forgotten dose.
Ne vzemite dvojnega odmerka (dveh odmerkov hkrati), če ste pozabili vzeti prejšnji odmerek.
General supportive care, including frequent monitoring of vital signs and close observation of the patient, is indicated.
Indicirana je splošna podporna oskrba, vključno s pogostim nadziranjem vitalnih znakov in natančnim opazovanjem bolnika.
- if you are pregnant or breast-feeding (see the section called ‘Pregnancy and breast-feeding').
- če ste noseči ali če dojite (glejte poglavje "Nosečnost in dojenje").
This may lower the mineral content of your bones.
To lahko zmanjša vsebnost mineralov v kosteh.
Your bones may be less strong and may be more likely to fracture.
Kosti lahko postanejo manj čvrste in poveča se verjetnost zlomov.
• Bleeding from the vagina (usually in the first few weeks of treatment - if the bleeding continues, talk to your doctor).
• krvavitev iz nožnice (po navadi v prvih nekaj tednih zdravljenja - če se krvavitev nadaljuje, se posvetujte z zdravnikom)
This is known as ‘angioedema'.
To je znano kot "angioedem".
However, the majority of these events occurred in patients with identifiable risk factors for the development of the condition.
Vendar se je večina teh primerov pojavila pri bolnikih s prepoznavnimi dejavniki tveganja za pojav te motnje.
Thirteen out of the 14 patients enrolled completed 12 months of combination treatment (one patient was lost to follow-up).
Dvanajstmesečno kombinirano zdravljenje je dokončalo 13 od 14 vključenih bolnikov (en bolnik se je izgubil spremljanju).
These effects occurred at clinically relevant doses.
Ti učinki so se pojavili pri klinično pomembnih odmerkih.
Multiple dose toxicity studies utilized rats and dogs.
V študijah toksičnosti več odmerkov so uporabili podgane in pse.
Estrone is subsequently converted to estradiol.
Estron se nato spremeni v estradiol.
There is no specific antidote to overdose and treatment must be symptomatic.
Specifičnega antidota za preveliko odmerjanje ni in zdravljenje mora biti simptomatsko.
Treatment should be based on a benefit-risk evaluation for the individual patient.
Zdravljenje mora temeljiti na oceni koristi in tveganja za vsako posamezno bolnico.
Very rarely symptoms of joint, stomach, and kidney pain may occur; this is known as ‘Henoch-Schönlein purpura'.
Zelo redko se lahko pojavijo simptomi v sklepih, želodcu in bolečine ledveno; to imenujemo "Henoch-Schönleinova purpura".
Treatment or prophylaxis for osteoporosis should be initiated as appropriate and carefully monitored.
Zdravljenje ali profilakso osteoporoze je treba začeti, kot je ustrezno, in ju natančno nadzirati.
The effect of potent CYP inhibitors is unknown.
Učinek močnih zaviralcev CYP ni znan.
Frequency groupings are defined according to the following convention: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to <1/1,000), and very rare (<1/10,000).
Skupine pogostnosti so opredeljene po naslednjem dogovoru: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000) in zelo redki (< 1/10.000).
- if you have ever had a condition that affects the strength of your bones (osteoporosis).
- če ste kdaj imeli bolezen, ki prizadene čvrstost kosti (osteoporozo).
The rate of prolonged (more than 24 weeks) stable disease, the rate of progression, and survival were also calculated.
Izračunani so bili tudi delež dolgotrajno stabilne bolezni (več kot 24 tednov), delež napredovanj in preživetje.
Two further similar trials (GABG/ARNO 95 and ITA), in one of which patients had received surgery and chemotherapy, as well as a combined analysis of ABCSG 8 and GABG/ARNO 95, supported these results.
Dve nadaljnji podobni preskušanji (GABG/ARNO 95 in ITA), v enem od katerih so bolnice zdravili z operacijo in kemoterapijo, ter kombinirana analiza ABCSG 8 in GABG/ARNO 95 potrjujejo te rezultate.
There were too few deaths occurring across treatment groups of both trials to draw conclusions on overall survival differences.
Smrti je bilo v terapevtskih skupinah obeh preskušanj premalo, da bi bilo mogoče sklepati o razliki v celokupnem v preživetju.
You should talk to your doctor about the risks and treatment options.
Z zdravnikom se posvetujte o tveganjih in o drugih možnostih zdravljenja.
Measured mean plasma concentrations were 44.4 (±14.7) ng/ml and 165 (±90) ng/ml respectively.
Izmerjena povprečna koncentracija v plazmi je bila 44,4 (± 14,7) ng/ml in 165 (± 90) ng/ml.
If any of these happen to you, call an ambulance or see a doctor straight away - you may need urgent medical treatment.
Če se vam pojavi kaj od tega, takoj pokličite reševalce ali pojdite k zdravniku - morda potrebujete nujno zdravniško pomoč.
Each film-coated tablet contains 93 mg of lactose monohydrate (see section 4.4).
Ena filmsko obložena tableta vsebuje 93 mg laktoze monohidrata (glejte poglavje 4.4).
The following table presents adverse reactions from clinical trials, post-marketing studies or spontaneous reports.
Naslednja preglednica prikazuje neželene učinke iz kliničnih preskušanj, postmarketinških študij in spontanih poročil.
In the management of an overdose, consideration should be given to the possibility that multiple agents may have been taken.
Pri obravnavi prevelikega odmerjanja je treba upoštevati možnost, da je bilo uporabljenih več zdravil.
- Swallow the tablet whole with a drink of water.
- Tableto zaužijte celo z nekaj vode.
p-value Overall survival e
vrednost p Celokupno preživetje e
Therefore, this SPC, labelling and package leaflet may not necessarily represent the current text.
Zato ta SmPC, označevanje in navodilo za uporabo mogoče potem ne bodo več predstavljali veljavnega besedila.
Adverse reactions listed below are classified according to frequency and System Organ Class (SOC).
Spodaj našteti neželeni učinki so razvrščeni po pogostnosti in organskem sistemu (SOC).
- Medicines that contain estrogen, such as hormone replacement therapy (HRT).
- Zdravila, ki vsebujejo estrogen, npr. hormonsko nadomestno zdravljenje (HNZ).
Only 14 subjects on Arimidex completed 36 months.
Samo 14 preiskovancev, ki so prejemali zdravilo Arimidex, je dokončalo 36 mesecev.
The incidence of osteoporosis was 10.5% in patients treated with Arimidex and 7.3% in patients treated with tamoxifen.
Incidenca osteoporoze je bila 10,5 % pri bolnicah, zdravljenih z zdravilom Arimidex in 7,3 % pri bolnicah, zdravljenih s tamoksifenom.
• Changes in special blood tests that show how your liver is working (gamma-GT and bilirubin).
• spremembe izvidov posebnih preiskav krvi, ki kažejo delovanje jeter (gama-GT in bilirubin)
Short stature due to Growth Hormone Deficiency
Nizka rast zaradi pomanjkanja rastnega hormona
This belongs to a group of medicines called ‘aromatase inhibitors'.
Ta spada v skupino zdravil, imenovanih "zaviralci aromataze".
Clearance of anastrozole was lower in girls (3-10 years) than in the older boys and exposure higher.
Očistek anastrozola je bil pri deklicah (starih od 3 do 10 let) manjši kot pri starejših dečkih, izpostavljenost pa je bila večja.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Če vam je zdravnik povedal, da imate intoleranco za nekatere sladkorje, se z njim posvetujte, preden vzamete to zdravilo.
Any venous thromboembolic event Deep venous thromboembolic events including PE (pulmonary embolism)
Katerikoli venski trombembolični dogodek Globoka venska trombembolija, vključno s PE (pljučno embolijo)
In boys with pubertal gynaecomastia (10-17 years), anastrozole was rapidly absorbed, was widely distributed, and was eliminated slowly with a half-life of approximately 2 days.
Pri dečkih s pubertetno ginekomastijo (starih od 10 do 17 let) se je anastrozol hitro absorbiral, se je široko porazdelil in se je odstranil počasi, z razpolovnim časom približno 2 dni.
Results from the secondary endpoints were supportive of the results of the primary efficacy endpoints.
Rezultati sekundarnih opazovanih dogodkov so potrjevali rezultate primarnih opazovanih dogodkov.
The recommended dose of Arimidex for adults including the elderly is one 1 mg tablet once a day.
Priporočeni odmerek zdravila Arimidex za odrasle (vključno s starejšimi) je ena 1-mg tableta enkrat na dan.
Do not use Arimidex after the expiry date which is stated on the carton and <container> [To be completed nationally].
Zdravila Arimidex ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in <vsebnik> [Izpolni država članica].
Hair thinning (alopecia) Allergic reactions
Pogosti redčenje las (alopecija) alergijske reakcije
Increases in alkaline phosphatase, alanine aminotransferase and aspartate aminotransferase
Pogosti zvišanje alkalne fosfataze, alaninaminotransferaze in aspartat-aminotransferaze
Mating indices were adversely affected in both dose groups, whilst a reduction in fertility was evident only at the 400 mg/l dose level.
Indeksi parjenja so bili slabši v obeh odmernih skupinah, zmanjšanje plodnosti pa je bilo opazno le pri odmerku 400 mg/l.
PHARMACEUTICAL FORM AND CONTENTS Film-coated tablet.
FARMACEVTSKA OBLIKA IN VSEBINA filmsko obložena tableta
Important information about some of the ingredients of Arimidex Arimidex contains lactose which is a type of sugar.
Pomembne informacije o nekaterih sestavinah zdravila Arimidex Zdravilo Arimidex vsebujejo laktozo, ki je vrsta sladkorja.
Table 3 ATAC endpoint summary: 5-year treatment completion analysis Efficacy endpoints
Preglednica 3 Povzetek na koncu ATAC: Analiza po končanem 5-letnem zdravljenju Končne točke učinkovitosti
Ischaemic cardiovascular disease Angina pectoris
Ishemična kardiovaskularna bolezen Angina pektoris
Growth rate (in cm/year) was significantly reduced (p<0.05) from pretreatment through month 0 to month 12, and from pre-treatment to the second 6 months (month 7 to month 12).
Hitrost rasti (v cm/leto) se je značilno zmanjšala (p < 0,05) od pred zdravljenja prek meseca nič do 12. meseca ter od pred zdravljenja do drugih 6 mesecev (od 7. do 12. meseca).
A decrease in 50% or more of total breast volume was seen in 56% (20/36) of the boys after 6 months.
Po 6 mesecih so zmanjšanje celotnega volumna prsi za 50 % ali več opazili pri 56 % (20/36) dečkov.
** Since cutaneous vasculitis and Henoch-Schönlein purpura was not observed in ATAC, the frequency category for these events can be considered as ‘Rare' (≥ 0.01% and < 0.1%) based on the worst value of the point estimate.
** Ker kožnega vaskulitisa in Henoch-Schönleinove purpure v ATAC niso zabeležili, je mogoče njuno pogostnost na podlagi najneugodnejše vrednosti točkovne ocene oceniti kot "redko" (≥ 0,01 % in
These effects were related to the pharmacological effects of the compound on parturition.
Ti učinki so bili povezani s farmakološkimi učinki spojine na porajanje.
Approximately 90 to 95% of plasma anastrozole steady-state concentrations are attained after 7 daily doses, and accumulation is 3- to 4-fold.
Približno 90 do 95 % koncentracije anastrozola v plazmi v stanju dinamičnega ravnovesja je doseženih po 7 dnevnih odmerkih in kopičenje je od 3- do 4-kratno.
Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Bolniki z redkimi prirojenimi motnjami, kot so galaktozna intoleranca, laponska oblika zmanjšane aktivnosti laktaze ali malabsorbcija glukoze-galaktoze, ne smejo jemati tega zdravila.
Anastrozole inhibits CYPs 1A2, 2C8/9 and 3A4 in vitro.
Anastrozol in vitro zavira CYP 1A2, 2C8/9 in 3A4.
This includes medicines that you buy without a prescription and herbal medicines.
To velja tudi za zdravila, ki ste jih dobili brez recepta, in za zeliščne pripravke.
AstraZeneca GmbH Tinsdaler Weg 183 D-22880 Wedel Germany
AstraZeneca GmbH Tinsdaler Weg 183 D-22880 Wedel Nemčija
The menopause should be defined biochemically (luteinizing-hormone [LH], follicle stimulating hormone [FSH], and/or estradiol levels) in any patient where there is doubt about menopausal status.
Menopavzo je treba ugotoviti biokemično (koncentracija luteinizirajočega hormona [LH], folikle stimulirajočega hormona [FSH] in/ali estradiola) pri vsaki bolnici, pri kateri obstaja dvom o menopavzalnem stanju.
These medicines are used to treat breast cancer, certain female health (gynaecological) conditions, and infertility.
Ta zdravila se uporabljajo za zdravljenje raka dojke, določenih ženskih (ginekoloških) bolezni in neplodnosti.
The efficacy of study treatment was based on the proportion of patients fulfilling defined criteria relating to vaginal bleeding, bone age, and growth velocity.
Učinkovitost raziskovanega zdravljenja je temeljila na deležu bolnic, ki so izpolnile opredeljena merila, povezana z nožničnimi krvavitvami, kostno starostjo in hitrostjo rasti.
• An extremely severe skin reaction with ulcers or blisters on the skin.
• izredno huda kožna reakcija z razjedami ali mehurji na koži.
It has not been determined whether the rates of fracture and osteoporosis seen in ATAC in patients on Arimidex treatment reflect a protective effect of tamoxifen, a specific effect of Arimidex, or both.
Ni ugotovljeno, ali deleži zlomov in osteoporoze, zabeleženi v študiji ATAC pri bolnicah, ki so prejemale zdravilo Arimidex, odraža zaščitni učinek tamoksifena, specifični učinek zdravila Arimidex ali oboje.
The metabolites are excreted primarily via the urine.
Presnovki se izločijo predvsem v urinu.
A review of the clinical trial safety database did not reveal evidence of clinically significant interaction in patients treated with Arimidex who also received other commonly prescribed medicinal products.
Pregled podatkovne baze o varnosti v kliničnih preskušanjih ni odkril klinično pomembnih medsebojnih delovanj pri bolnikih, zdravljenih z zdravilom Arimidex, ki so prejemali tudi druga pogosto predpisovana zdravila.
This includes gonadorelin, buserelin, goserelin, leuprorelin and triptorelin.
Med takšna spadajo gonadorelin, buserelin, goserelin, levprorelin in triptorelin.
Note: This SPC, labelling and packages leaflet is the version valid at the time of Commission Decision.
Opomba: Ta povzetek glavnih značilnosti zdravila (SmPC), označevanje in navodilo za uporabo so različice, veljavne ob izdaji odločbe Komisije.
With an updated follow-up at a median of 10 years, long term comparison of the treatment effects of Arimidex relative to tamoxifen were shown to be consistent with previous analyses.
Ob posodobljenem spremljanju po mediano 10 letih je dolgoročna primerjava učinkov zdravljenja z zdravilom Arimidex v primerjavi s tamoksifenom pokazala rezultate, skladne s prejšnjimi analizami.
This treatment arm was discontinued from the study.
Ta terapevtski krak je bil v študiji opuščen.
McCune-Albright Syndrome study
Študija McCune-Albrightovega sindroma
• Carpal tunnel syndrome (tingling, pain, coldness, weakness in parts of the hand).
• sindrom zapestnega kanala (mravljinčenje, bolečine, hlad, šibkost v delih dlani)
This is because Arimidex can affect the way some medicines work and some medicines can have an effect on Arimidex.
Zdravilo Arimidex namreč lahko vpliva na delovanje nekaterih zdravil in nekatera zdravila lahko vplivajo na zdravilo Arimidex.
There are no data to support the use of Arimidex with LHRH analogues.
Ni podatkov, ki bi podpirali uporabo zdravila Arimidex z analogi LHRH.
The primary objective was to evaluate the safety and efficacy of Arimidex 1 mg/day in patients with MAS.
Primarni cilj je bila ocena varnosti in učinkovitosti zdravila Arimidex v odmerku 1 mg/dan pri bolnicah z MAS.
Triazole, the major metabolite in plasma, does not inhibit aromatase.
Triazol, glavni presnovek v plazmi, ne zavira aromataze.
*** Vaginal bleeding has been reported commonly, mainly in patients with advanced breast cancer during the first few weeks after changing from existing hormonal therapy to treatment with Arimidex.
*** Pogosto je bila opisana krvavitev iz nožnice, predvsem pri bolnicah z napredovalim rakom dojke v prvih nekaj tednih po prehodu z obstoječega hormonskega zdravljenja na zdravljenje z zdravilom Arimidex.
No data on the potential long-term effects of Arimidex treatment in children and adolescents are available (see also section 5.3).
Podatkov o morebitnih dolgoročnih učinkih zdravljenja z zdravilom Arimidex pri otrocih in mladostnikih ni (glejte tudi poglavje 5.3).
• Feeling weak.
• občutek šibkosti
• Skin rash caused by hypersensitivity (this can be from allergic or anaphylactoid reaction).
• izpuščaj na koži, ki ga povzroči preobčutljivost (ta je lahko zaradi alergijske ali anafilaktoidne reakcije)
Anastrozole is eliminated slowly with a plasma elimination half-life of 40 to 50 hours.
Anastrozol se odstrani počasi; plazemski eliminacijski razpolovni čas je od 40 do 50 ur.
Absorption of anastrozole is rapid and maximum plasma concentrations typically occur within two hours of dosing (under fasted conditions).
Absorpcija anastrozola je hitra in največja koncentracija v plazmi je praviloma dosežena v dveh urah po uporabi (na tešče).
Use in children Arimidex should not be given to children and adolescents.
Uporaba pri otrocih Zdravila Arimidex se ne sme dajati otrokom in mladostnikom.
It may harm them, even if their symptoms are the same as yours.
čeprav imajo znake bolezni, podobne vašim.
Arimidex contains a substance called anastrozole.
Zdravilo Arimidex vsebuje snov, imenovano anastrozol.
There was no significant difference in growth rate after 12 months of treatment, relative to the growth rate during the 6 months prior to entering the study.
Po 12 mesecih zdravljenja ni bilo nobene značilne razlike v hitrosti rasti glede na hitrost rasti v 6 mesecih pred vstopom v študijo.
Stevens-Johnson syndrome Angioedema
Stevens-Johnsonov sindrom angioedem
Ischaemic cerebrovascular events Endometrial cancer
Ishemični cerebrovaskularni dogodki Rak endometrija
Tell your doctor or pharmacist if you are taking the following: - A medicine known as an ‘LHRH analogue'.
Zdravniku ali farmacevtu morate povedati, če jemljete katero od naslednjih zdravil: - Zdravilo, imenovano "analog LHRH".
These changes occurred at a dose which represents 100-fold greater exposure than occurs at human therapeutic doses, and are considered not to be clinically relevant to the treatment of patients with anastrozole.
Te spremembe so se pojavile v odmerku, ki predstavlja 100-krat večjo izpostavljenost, kot je dosežena s terapevtskimi odmerki za človeka, in ne veljajo za klinično pomembne pri zdravljenju bolnikov z anastrozolom.
Those effects that were seen (placental enlargement in rats and pregnancy failure in rabbits) were related to the pharmacology of the compound.
Opaženi učinki (povečanje placente pri podganah in neuspeh brejosti pri kunkah) so bili povezani s farmakologijo spojine.
• Allergic (hypersensitivity) reactions including face, lips, or tongue.
• alergijske (preobčutljivostne) reakcije, ki zajamejo obraz, ustnice ali jezik.
Table 4 ABCSG 8 trial endpoint and results summary Efficacy endpoints
Preglednica 4 Povzetek končnih točk in rezultatov preskušanja ABCSG 8 Končne točke učinkovitosti
If you take more Arimidex than you should If you take more Arimidex than you should, talk to a doctor straight away.
Če ste vzeli večji odmerek zdravila Arimidex, kot bi smeli Če ste vzeli večji odmerek zdravila Arimidex, kot bi smeli, se takoj posvetujte z zdravnikom.
In the pivotal clinical trial, efficacy was not demonstrated and safety was not established (see section 5.1).
V ključnem kliničnem preskušanju učinkovitost ni bila dokazana in varnost ni bila ugotovljena (glejte poglavje 5.1).
It does this by blocking a natural substance (an enzyme) in your body called ‘aromatase'.
To doseže z blokado naravne telesne snovi (encima), imenovane "aromataza".
Anastrozole is only 40% bound to plasma proteins.
Zdravilo Arimidex je 40 % vezano na beljakovine v plazmi.
‘Stevens-Johnson syndrome'.
To je znano kot "Stevens-Johnsonov sindrom".
Women with osteoporosis or at risk of osteoporosis, should have their bone mineral density formally assessed at the commencement of treatment and at regular intervals thereafter.
Ženske z osteoporozo ali tveganjem zanjo morajo na začetku zdravljenja in pozneje v rednih presledkih opraviti formalno oceno mineralne gostote kosti.
White, round, biconvex tablet with logo on one side and strength on the other.
Bela, okrogla bikonveksna tableta z logom na eni strani in jakostjo na drugi.
These effects were related to the pharmacology of the compound and were completely reversed after a 5-week compound withdrawal period.
Ti učinki so bili povezani s farmakologijo spojine in so popolnoma izginili 5 tednov po odtegnitvi spojine.
Do not take Arimidex if you are pregnant or breast-feeding.
Ne jemljite zdravila Arimidex, če ste noseči ali dojite.
What Arimidex is and what it is used for Before you take Arimidex How to take Arimidex Possible side effects
Kaj je zdravilo Arimidex in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Arimidex Kako jemati zdravilo Arimidex Možni neželeni učinki
Anastrozole in girls was widely distributed and slowly eliminated.
Anastrozol se je pri deklicah porazdelil širše in se je odstranil počasneje.
Arimidex is a potent and highly selective non-steroidal aromatase inhibitor.
Arimidex je močan in zelo selektiven nesteroiden zaviralec aromataze.
Your doctor will manage these risks according to treatment guidelines for managing bone health in women who have gone through the menopause.
Zdravnik bo obvladal ta tveganja v skladu s smernicami za zagotavljanje zdravja kosti pri ženskah, ki so že imele menopavzo.
Arimidex should be taken orally.
Zdravilo Arimidex je treba jemati peroralno.
The European Medicines Agency has waived the obligation to submit the results of studies with Arimidex in one or several subsets of the paediatric population in short stature due to growth hormone deficiency (GHD), testotoxicosis, gynaecomastia, and McCune-Albright syndrome (see section 4.2).
Evropska agencija za zdravila je odstopila od obveznosti po predložitvi rezultatov študij zdravila Arimidex pri eni ali več podskupinah pediatrične populacije z nizko rastjo zaradi pomanjkanja rastnega hormona, testotoksikozo, ginekomastijo in McCune-Albrightovim sindromom (glejte poglavje 4.2).
If you go into the hospital, let the medical staff know you are taking Arimidex.
Če greste v bolnišnico, morate zdravstvenemu osebju povedati, da jemljete zdravilo Arimidex.